Form 8-K - Current report:
SEC Accession No. 0001193125-24-198309
Filing Date
2024-08-12
Accepted
2024-08-12 06:08:00
Documents
20
Period of Report
2024-08-09
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 1.02: Termination of a Material Definitive Agreement
Item 2.02: Results of Operations and Financial Condition
Item 3.02: Unregistered Sales of Equity Securities
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d755257d8k.htm   iXBRL 8-K 58771
2 EX-4.1 d755257dex41.htm EX-4.1 106287
3 EX-10.1 d755257dex101.htm EX-10.1 845179
4 EX-10.2 d755257dex102.htm EX-10.2 409766
8 GRAPHIC g755257g0811003114132.jpg GRAPHIC 23989
9 GRAPHIC g755257g0811003114433.jpg GRAPHIC 15965
10 GRAPHIC g755257g0811003114673.jpg GRAPHIC 8530
11 GRAPHIC g755257g0811003114899.jpg GRAPHIC 19773
  Complete submission text file 0001193125-24-198309.txt   2043308

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA scph-20240809.xsd EX-101.SCH 2880
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE scph-20240809_lab.xml EX-101.LAB 17994
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE scph-20240809_pre.xml EX-101.PRE 11281
22 EXTRACTED XBRL INSTANCE DOCUMENT d755257d8k_htm.xml XML 3633
Mailing Address 25 BURLINGTON MALL ROAD, SUITE 203 BURLINGTON MA 01803
Business Address 25 BURLINGTON MALL ROAD, SUITE 203 BURLINGTON MA 01803 617-517-0730
scPharmaceuticals Inc. (Filer) CIK: 0001604950 (see all company filings)

EIN.: 465184075 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38293 | Film No.: 241194632
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)